Everbright logo

Everbright

Asia, Hong Kong Island, Hong Kong, Wan Chai

Description

Everbright is China’s cross-border investment and asset management company.

Investor Profile

Everbright has backed more than 11 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 9 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Private Equity, Series C rounds (top funding stages).
  • Majority of deals are located in China, United States, Hong Kong.
  • Strong thematic focus on Health Care, Manufacturing, Biotechnology.

Stage Focus

  • Series A (36%)
  • Private Equity (18%)
  • Series C (18%)
  • Series D (9%)
  • Series Unknown (9%)
  • Series B (9%)

Country Focus

  • China (73%)
  • United States (18%)
  • Hong Kong (9%)

Industry Focus

  • Health Care
  • Manufacturing
  • Biotechnology
  • Medical
  • Logistics
  • Real Estate
  • Real Estate Investment
  • Warehousing
  • Fintech
  • Internet
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Everbright frequently co-invest with?

Huarong International Financial Holdings
Asia, Beijing, China, Beijing
Co-Investments: 1
Frees Fund
Asia, Beijing, China, Beijing
Co-Investments: 2
Loyal Valley Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 2
GI
North America, Florida, United States, Sunrise
Co-Investments: 1
Lighthouse Capital Partners
North America, California, United States, Menlo Park
Co-Investments: 2
China Growth Capital | CGC
Asia, Beijing, China, Beijing
Co-Investments: 2
SI
Oceania, Victoria, Australia, Melbourne
Co-Investments: 1
China Merchants Venture Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
GGV Capital
North America, California, United States, Menlo Park
Co-Investments: 1
Everbright Securities
Asia, Shanghai, China, Shanghai
Co-Investments: 1

What are some of recent deals done by Everbright?

Xinyi Electronic Technology

Qingpu, Shanghai, China

Xinyi Electronics is a high-tech enterprise focusing on the research and development

Artificial Intelligence (AI)Information Technology
Series AJul 17, 2025
IASO Biotherapeutics

Nanjing, Jiangsu, China

IASO Biotherapeutics is a biopharmaceutical company focused on the development of cell therapies in the field of oncology.

BiotechnologyOncologyPharmaceutical
Series CSep 16, 2021
Amount Raised: $108,000,000
Hedonova

Los Angeles, California, United States

Global alternative investment management

Asset ManagementHedge Funds
Series ANov 26, 2020
Amount Raised: $7,000,000
Juvenile Get

Beijing, Beijing, China

Juvenile Get is a learning and counseling application for primary and secondary schools,

E-LearningEducation
Series ANov 14, 2019
Amount Raised: $14,243,391
Tongdun Technology

Shenzhen, Guangdong, China

Tongdun Technology is an artificial intelligence-based decision-making intelligence platform.

FinTechInternetNetwork SecuritySoftware
Series DApr 25, 2019
Amount Raised: $100,000,000
Dedao

Cangzhou, Hebei, China

Dedao is an auto parts manufacturer.

AutomotiveMachinery ManufacturingManufacturing
Series AJan 1, 2019
Amount Raised: $14,000,000
NetEase Cloud Music

Beijing, Beijing, China

NetEase Cloud Music operates an online music platform and offers streaming services.

Digital MediaMedia and EntertainmentMusicMusic Streaming
Series BNov 13, 2018
Amount Raised: $600,000,000
ESR

Central, Hong Kong Island, Hong Kong

ESR is a pan-Asia logistics real estate developer and operator.

LogisticsReal EstateReal Estate InvestmentWarehousing
Private EquityJan 6, 2017
Amount Raised: $300,000,000
Ambrx

La Jolla, California, United States

Ambrx is a clinical-stage biopharmaceutical company using expanded genetic code technology for next-gen therapies and immune modulation.

BiopharmaBiotechnologyHealth CareLife ScienceTherapeutics
Series UnknownAug 4, 2016
Amount Raised: $45,000,000

Amcare Women's and Children's Hospital provides gynecology, obstetrics, and pediatric medical services for Chinese families.

Health CareHospitalMedical
Private EquityNov 16, 2013
Amount Raised: $100,000,000